These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 16436641)

  • 21. Detection of cytokeratin-19 transcripts by reverse transcriptase-polymerase chain reaction in lung cancer cell lines and blood of lung cancer patients.
    Dingemans AM; Brakenhoff RH; Postmus PE; Giaccone G
    Lab Invest; 1997 Sep; 77(3):213-20. PubMed ID: 9314945
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential expression of carcinoembryonic antigen (CEA) splice variants in whole blood of colon cancer patients and healthy volunteers: implication for the detection of circulating colon cancer cells.
    Hampton R; Walker M; Marshall J; Juhl H
    Oncogene; 2002 Nov; 21(51):7817-23. PubMed ID: 12420218
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detection of circulating breast cancer cells by reverse transcriptase polymerase chain reaction (RT-PCR).
    Hu XC; Chow LW
    Eur J Surg Oncol; 2000 Sep; 26(6):530-5. PubMed ID: 11034801
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detection of micrometastasis by cytokeratin-20 (reverse transcription polymerase chain reaction) in lymph nodes of patients with endometrial cancer.
    Fishman A; Klein A; Zemer R; Zimlichman S; Bernheim J; Cohen I; Altaras MM
    Gynecol Oncol; 2000 Jun; 77(3):399-404. PubMed ID: 10831349
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased detection of circulating tumor cells in the blood of colorectal carcinoma patients using two reverse transcription-PCR assays and multiple blood samples.
    Wharton RQ; Jonas SK; Glover C; Khan ZA; Klokouzas A; Quinn H; Henry M; Allen-Mersh TG
    Clin Cancer Res; 1999 Dec; 5(12):4158-63. PubMed ID: 10632355
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular detection of cytokeratin-19-positive cells in the peripheral blood of patients with operable breast cancer: evaluation of their prognostic significance.
    Stathopoulou A; Vlachonikolis I; Mavroudis D; Perraki M; Kouroussis Ch; Apostolaki S; Malamos N; Kakolyris S; Kotsakis A; Xenidis N; Reppa D; Georgoulias V
    J Clin Oncol; 2002 Aug; 20(16):3404-12. PubMed ID: 12177100
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Detection of occult cancer cells in peripheral blood and bone marrow by quantitative RT-PCR assay for cytokeratin-7 in breast cancer patients.
    Masuda TA; Kataoka A; Ohno S; Murakami S; Mimori K; Utsunomiya T; Inoue H; Tsutsui S; Kinoshita J; Masuda N; Moriyama N; Mori M
    Int J Oncol; 2005 Mar; 26(3):721-30. PubMed ID: 15703829
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Heterogeneous expression of MAGE-A genes in occult disseminated tumor cells: a novel multimarker reverse transcription-polymerase chain reaction for diagnosis of micrometastatic disease.
    Kufer P; Zippelius A; Lutterbüse R; Mecklenburg I; Enzmann T; Montag A; Weckermann D; Passlick B; Prang N; Reichardt P; Dugas M; Köllermann MW; Pantel K; Riethmüller G
    Cancer Res; 2002 Jan; 62(1):251-61. PubMed ID: 11782385
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Clinical significance of detecting lymph node micrometastasis of colorectal cancer by reverse transcriptase-polymerase chain reaction (RT-PCR)].
    Yuan HY; Cheng FL; Wei ZZ; Yang GL; Chen JK
    Ai Zheng; 2004 Sep; 23(9):1069-73. PubMed ID: 15363204
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cytokeratin 20 is not a tissue-specific marker for the detection of malignant epithelial cells in the blood of colorectal cancer patients.
    Bustin SA; Gyselman VG; Siddiqi S; Dorudi S
    Int J Surg Investig; 2000; 2(1):49-57. PubMed ID: 12774338
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Limitations of the reverse transcription-polymerase chain reaction method for the detection of carcinoembryonic antigen-positive tumor cells in peripheral blood.
    Ko Y; Klinz M; Totzke G; Gouni-Berthold I; Sachinidis A; Vetter H
    Clin Cancer Res; 1998 Sep; 4(9):2141-6. PubMed ID: 9748132
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detection of breast cancer micrometastases in axillary lymph nodes by means of reverse transcriptase-polymerase chain reaction. Comparison between MUC1 mRNA and keratin 19 mRNA amplification.
    Noguchi S; Aihara T; Motomura K; Inaji H; Imaoka S; Koyama H
    Am J Pathol; 1996 Feb; 148(2):649-56. PubMed ID: 8579127
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quantitative real-time RT-PCR detection for survivin, CK20 and CEA in peripheral blood of colorectal cancer patients.
    Shen C; Hu L; Xia L; Li Y
    Jpn J Clin Oncol; 2008 Nov; 38(11):770-6. PubMed ID: 18845519
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detecting carcinoma cells in peripheral blood of patients with hepatocellular carcinoma by immunomagnetic beads and rt-PCR.
    Guo J; Yao F; Lou Y; Xu C; Xiao B; Zhou W; Chen J; Hu Y; Liu Z
    J Clin Gastroenterol; 2007 Sep; 41(8):783-8. PubMed ID: 17700428
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quantitative detection of cytokeratin 20 mRNA in urine samples as diagnostic tools for bladder cancer by real-time PCR.
    Guo B; Luo C; Xun C; Xie J; Wu X; Pu J
    Exp Oncol; 2009 Mar; 31(1):43-7. PubMed ID: 19300416
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Detection of cytokeratin20 mRNA in peripheral blood from colonic cancer patients by fluorescence quantitative polymerase chain reaction].
    Wang ZC; Wang C; Zeng QG
    Zhonghua Zhong Liu Za Zhi; 2007 Aug; 29(8):600-3. PubMed ID: 18210880
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The detection of circulating breast cancer cells in peripheral blood by reverse transcriptase-polymerase chain reaction.
    Bae JW; Choi KH; Kim HG; Park SH
    J Korean Med Sci; 2000 Apr; 15(2):194-8. PubMed ID: 10803697
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Usefulness and clinical significance of quantitative real-time RT-PCR to detect isolated tumor cells in the peripheral blood and tumor drainage blood of patients with colorectal cancer.
    Iinuma H; Okinaga K; Egami H; Mimori K; Hayashi N; Nishida K; Adachi M; Mori M; Sasako M
    Int J Oncol; 2006 Feb; 28(2):297-306. PubMed ID: 16391782
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of cytokeratin 20 in urinary cytology of patients with bladder carcinoma.
    Klein A; Zemer R; Buchumensky V; Klaper R; Nissenkorn I
    Cancer; 1998 Jan; 82(2):349-54. PubMed ID: 9445193
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Real-time PCR (TaqMan PCR) quantification of carcinoembryonic antigen (CEA) mRNA in the peripheral blood of colorectal cancer patients.
    Miura M; Ichikawa Y; Tanaka K; Kamiyama M; Hamaguchi Y; Ishikawa T; Yamaguchi S; Togo S; Ike H; Ooki S; Shimada H
    Anticancer Res; 2003; 23(2B):1271-6. PubMed ID: 12820382
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.